QTTB - Total Utang marang Modal Q32 Bio
As a biotechnology business, Q32 Bio Inc. (QTTB) strictly adheres to environmental regulations by minimizing toxic emissions and utilizing recycled packaging. Experienced management effectively advances developments toward final trial stages, leveraging the trust of major partners. This price chart reflects a total debt-to-equity ratio of 0.05, which complements the antibody development strategy driven by scientific and financial alliances with pharma behemoths.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_QTTB_-_Q32-Bio-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "QTTB (Q32 Bio) riwayat Total Utang marang Modal saka 27.03.2024 nganti 29.10.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Q32 Bio Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Analisis dhasar perusahaan:Q32 Bio Inc.
For the biopharmaceutical company Q32 Bio Inc. (QTTB), which operates in the innate immunity therapy segment, managing capital structure is critical when financing costly research and development. By analyzing the total liabilities-to-equity chart, an investor determines the proportion of debt relative to equity, allowing for an assessment of the business's financial stability and the risk of share devaluation in the event of excessive leverage.
Analisis pesaing Q32 Bio Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA - Utang marang Ekuitas|Rasio Utang marang Modal Savara Pharma (SVRA)|RIGL (Rigel Pharmaceuticals) - Rasio Total Utang marang Ekuitas|ANAB (anaptysbio.com) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ATXS|ENGN: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal RAPT|Utang marang Ekuitas JBIO (aerovatetx.com)|Total Utang marang Modal ACRS (Aclaris Therapeutics)|Koefisien Total Utang marang Modal kyvernatx.com (KYTX)|TLSA - Utang marang Ekuitas|Utang marang Modal Cabaletta Bio Inc.|VTYX (Ventyx Bio) - Rasio Total Utang marang Ekuitas|Theratechnologies, Inc - Rasio Kabeh Utang marang Dana Pribadi|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|eledon.com (ELDN) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Agenus Inc. (AGEN)|Climb Bio Inc. - Rasio Utang marang Ekuitas|Total Utang marang Modal ZURA (Zura Bio Limited)|ATYR - Rasio Total Utang marang Ekuitas|ADAG: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal ImageneBio Inc IMA|shattucklabs.com (STTK) - Utang marang Ekuitas|Rasio Utang marang Modal Equillium EQ|Rasio Total Utang marang Ekuitas CNTB|IMUX (Immunic Inc) - Utang Agregat marang Modal|Rasio Total Utang marang Ekuitas ATRA (Atara Biotherapeutics)|Utang Agregat marang Modal IFRX|Total Utang marang Modal XFOR (X4 Pharmaceuticals, Inc.)|Adicet Bio Inc. - Utang marang Ekuitas|CELU - Utang marang Ekuitas|Utang Agregat marang Ekuitas INMB|BRNS: Total Utang marang Modal|kezarlifesciences.com - Rasio Kabeh Utang marang Dana Pribadi|SABS (SAB Biotherapeutics, Inc.) - Total Utang marang Modal|Total Utang marang Modal Akari Therapeutics PLC|Utang marang Ekuitas Enlivex Therapeutics (ENLV)|GOVX (GeoVax Corp) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Edesa Biotech, Inc. EDSA|IBIO - Rasio Total Utang marang Ekuitas|Carisma Tx - Total Utang marang Modal|XTLB - Total Utang marang Modal|BOLT (boltbio.com) - Rasio Total Utang marang Ekuitas|HCW Biologics - Rasio Kabeh Utang marang Dana Pribadi|APVO (Aptevo Therapeutics, Inc.) - Total Utang marang Modal|AIM ImmunoTech, Inc. (AIM) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Aditxt (ADTX)|Rasio Total Utang marang Ekuitas GRI Bio Inc GRI|Utang marang Ekuitas XORTX XRTX|HIND - Rasio Total Utang marang Ekuitas|REVB: Rasio Total Utang marang Ekuitas|INDP - Total Utang marang Modal|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CALI|AFMD (Affimed NV) - Total Utang marang Modal|Utang marang Modal Allakos Therapeutics ALLK|Utang marang Ekuitas HOOKIPA Pharma Inc. (HOOK)|igmbio.com (IGMS) - Rasio Utang marang Modal|iTeos Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|Ocean Biomedical Inc - Utang marang Ekuitas|TCBP: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi THRD (Third Harmonic Bio Inc)